BioStabilization Systems (BoSS)

The ARPA‑H “BoSS” solicitation (ARPA‑H‑SOL‑26‑136) seeks innovative, technically feasible solutions that advance the agency’s biomedical mission through a defined set of program metrics covering technology processes, output (e.g., stabilized cells), commercialization, and regulatory engagement. Proposers must submit a conforming Solution Summary and a Solution Pitch presentation that detail a complete technical approach, identified risks with mitigation plans, a clear commercialization strategy, and an intellectual‑property structure that does not impede government transition. Evaluation will be based on four criteria: (1) overall scientific and technical merit, including regulatory readiness and IP considerations; (2) proposer’s capabilities and relevant experience, with required documentation of team expertise or, if non‑commercial, a teaming arrangement to support early commercialization; (3) potential contribution to ARPA‑H’s mission and user experience, emphasizing unmet biomedical needs, interdisciplinary impact, and accessibility; and (4) reasonableness of cost/price, substantiated by detailed labor, material, equipment, travel, and other cost estimates. Eligibility excludes entities with existing funding for the same concept and limits participation by FFRDCs or other government entities unless a unique capability is essential and documented. Submissions must meet all formatting and content requirements; non‑conforming proposals may be rejected without review. The solicitation also calls for an Independent Validation and Verification (IV&V) partner and outlines handling of selection‑sensitive information and award procedures.

Notice ID

aadd5b36db484e0a8f4e29d77af9f081

Solicitation Number

ARPA-H-SOL-26-136

NAICS Code

541715

Classification Code

AN13